This workshop enabled all to agree on the relevance of EPIS VPD to be used as a platform for the reporting and monitoring of measles outbreak in the EU, agree on the type of information to be reported, the nature of outbreaks to be notified and the further usage by ECDC (e.g. European Monthly Measles Monitoring1) and other Member States of data that will be shared through EPIS VPD by countries.
A meeting and a workshop on the ECDC point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use in acute care hospitals took take place in London on 5-6 March 2012.
Influenza viruses pose a particular challenge for those designing vaccines for humans. Much of the protective immunity that humans have against these viruses following natural infection or vaccination is due to immunological recognition of the haemagglutinin (HA) surface glycoprotein.
On the 22 November 2011, ECDC organised a workshop at the European Parliament to provide policy makers with more information on the facts about seasonal influenza vaccination and on ECDC’s contributions to the implementation of the 2009 Council Recommendation on this subject.